Blockchain Registration Transaction Record

Biotech Giants Embrace Platform Models to Maximize Drug Delivery Value

Biotech companies like Oncotelic Therapeutics are using nanotechnology and AI to improve drug delivery of existing cancer therapies, targeting a $410B market. Learn about the platform shift.

This news matters because it signals a fundamental shift in biotech strategy from relying solely on new drug discoveries to maximizing the potential of existing therapies through advanced delivery technologies. For investors, this trend offers opportunities in platform-based companies like Oncotelic Therapeutics, which may provide more diversified and scalable revenue streams. For patients, improved drug delivery could mean more effective treatments with fewer side effects, particularly in oncology. The projected $410 billion drug delivery market underscores the economic significance, potentially reshaping how drugs are developed and commercialized.